Bacterial Resistance to Penicillins and Cephalosporins

The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the Royal Society of London. Series B, Biological sciences Biological sciences, 1971-12, Vol.179 (1057), p.403-410
1. Verfasser: Rolinson, G. N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 1057
container_start_page 403
container_title Proceedings of the Royal Society of London. Series B, Biological sciences
container_volume 179
creator Rolinson, G. N.
description The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtieth anniversary of the introduction of penicillin into medicine it seemed to me that it would be appropriate to consider primarily the changes which have taken place over this period in the incidence of resistance and the knowledge which has been gained concerning the nature of resistance to this family of antibiotics. Before we look at what the changes in resistance have been, however, it may be useful to consider what one means by the word resistant, and in fact one uses the word in two rather different ways. Used in one sense the term applies to those species of bacteria which are characteristically insensitive to penicillin, for example one may say that Pseudomonas aeruginosa is resistant to benzylpenicillin, because this is a characteristic of the species. On the other hand, the term resistant is also applied to particular strains of species of bacteria which are typically penicillin sensitive, or at least were typically sensitive at the time penicillin was first introduced into medicine, for example penicillin-resistant strains of staphylococci and penicillinresistant gonococci. As a result of these two uses of the word resistant some anomalies appear to arise. For example, strains of Escherichia coli inhibited by ampicillin at a concentration of 2 μg/ml would certainly be considered sensitive, whereas strains of gonococci inhibited by one-tenth of this concentration would be regarded as resistant and this is because typical sensitive strains are inhibited by even lower levels. Again, strains of Ps. aeruginosa requiring for inhibition a concentration of gentamicin of 10 μg/ml would be said to be resistant, but strains inhibited by carbenicillin at a level as high as 50 μg/ml are considered sensitive. Here the reason is toxicity: a level of 10 μg/ml of gentamicin could not safely be maintained in the body, whereas a level of 50 μg/ml carbenicillin can. Clearly there are two criteria for judging organisms to be resistant, one is that the concentration of drug required to inhibit growth is a level which cannot readily be achieved at the site of infection and the other is simply that the minimum inhibitory concentration is significantly higher than that of the
doi_str_mv 10.1098/rspb.1971.0105
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_jstor_primary_75980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>75980</jstor_id><sourcerecordid>75980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-f41a55ea489d2f12ec87fd044c152ce4a0989422f3ff5fd659ebf4a2204e8aeb3</originalsourceid><addsrcrecordid>eNp9kM1r3DAQxUVpSbdJrz0UCj715s3oy5aOzdIvCCSk6Vlo5RHV4rVcyQ5s__rK2SVQSnsSo_nNm3mPkDcU1hS0ukx53K6pbukaKMhnZMVA8lpTzZ-TFYCCWjRCvySvct4BiEZrfkbOhAAqqFqR5sq6CVOwfXWHOeTJDg6rKVa3OAQX-j4MubJDV21w_GH7mMeYytcFeeFtn_H16T0n3z99vN98qa9vPn_dfLiuHdd8qr2gVkq0QumOecrQqdZ3IISjkjkUtjjQgjHPvZe-a6TGrReWMRCoLG75OXl_1B1T_Dljnsw-ZId9bweMczaK8mKbQwHXR9ClmHNCb8YU9jYdDAWzBGWWoMwSlFmCKgPvTsrzdo_dE35KpvTzsZ_ioTiMLuB0MLs4p6GU5u7b7RXVUj_QVoei1xpQnEIDlDXmVxgf1y2AKYAJOc9oHrE_z_j7Kv6_rf_08vY4tctTTE9WWqkV8N9q-qMo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81301030</pqid></control><display><type>article</type><title>Bacterial Resistance to Penicillins and Cephalosporins</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Rolinson, G. N.</creator><creatorcontrib>Rolinson, G. N.</creatorcontrib><description>The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtieth anniversary of the introduction of penicillin into medicine it seemed to me that it would be appropriate to consider primarily the changes which have taken place over this period in the incidence of resistance and the knowledge which has been gained concerning the nature of resistance to this family of antibiotics. Before we look at what the changes in resistance have been, however, it may be useful to consider what one means by the word resistant, and in fact one uses the word in two rather different ways. Used in one sense the term applies to those species of bacteria which are characteristically insensitive to penicillin, for example one may say that Pseudomonas aeruginosa is resistant to benzylpenicillin, because this is a characteristic of the species. On the other hand, the term resistant is also applied to particular strains of species of bacteria which are typically penicillin sensitive, or at least were typically sensitive at the time penicillin was first introduced into medicine, for example penicillin-resistant strains of staphylococci and penicillinresistant gonococci. As a result of these two uses of the word resistant some anomalies appear to arise. For example, strains of Escherichia coli inhibited by ampicillin at a concentration of 2 μg/ml would certainly be considered sensitive, whereas strains of gonococci inhibited by one-tenth of this concentration would be regarded as resistant and this is because typical sensitive strains are inhibited by even lower levels. Again, strains of Ps. aeruginosa requiring for inhibition a concentration of gentamicin of 10 μg/ml would be said to be resistant, but strains inhibited by carbenicillin at a level as high as 50 μg/ml are considered sensitive. Here the reason is toxicity: a level of 10 μg/ml of gentamicin could not safely be maintained in the body, whereas a level of 50 μg/ml carbenicillin can. Clearly there are two criteria for judging organisms to be resistant, one is that the concentration of drug required to inhibit growth is a level which cannot readily be achieved at the site of infection and the other is simply that the minimum inhibitory concentration is significantly higher than that of the majority of strains of that particular species. Resistance to penicillins and cephalosporins, as with other antibiotics, may arise in bacteria in one of two ways. Resistance may occur as a result of chromosomal mutation or it may arise as a result of the transfer of genetic information from a resistant bacterial cell to a sensitive cell and this transfer may take place by transformation or by conjugation or by the phage mediated process of transduction. Resistant strains, once they arise, may be at a selectional advantage when the drug is used and as a result they may become more prevalent. The frequency at which antibiotic resistant strains arise, and the rate at which they subsequently increase in numbers, varies greatly with different antibiotics and different pathogens and some of the changes in bacterial resistance to penicillins which have occurred over the past 30 years are shown in diagrammatic form in figure 1.</description><identifier>ISSN: 0080-4649</identifier><identifier>ISSN: 0950-1193</identifier><identifier>EISSN: 2053-9193</identifier><identifier>DOI: 10.1098/rspb.1971.0105</identifier><identifier>PMID: 4401418</identifier><language>eng</language><publisher>London: The Royal Society</publisher><subject>Antibiotics ; Bacteria ; Cephalosporins ; Cephalosporins - pharmacology ; Enterobacteriaceae - drug effects ; Enterobacteriaceae - enzymology ; Enterococcus faecalis - drug effects ; Escherichia coli - drug effects ; Haemophilus influenzae - drug effects ; Infections ; Klebsiella ; Klebsiella - drug effects ; Mutation ; Neisseria gonorrhoeae ; Neisseria gonorrhoeae - drug effects ; Pathogens ; Penicillin ; Penicillin Resistance ; Penicillinase - metabolism ; Penicillins - pharmacology ; Proteus mirabilis - drug effects ; Pseudomonas aeruginosa - drug effects ; Staphylococcus ; Staphylococcus - drug effects ; Streptococcus pyogenes - drug effects ; Structure-Activity Relationship ; Transformation, Genetic</subject><ispartof>Proceedings of the Royal Society of London. Series B, Biological sciences, 1971-12, Vol.179 (1057), p.403-410</ispartof><rights>Scanned images copyright © 2017, Royal Society</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-f41a55ea489d2f12ec87fd044c152ce4a0989422f3ff5fd659ebf4a2204e8aeb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/75980$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/75980$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4401418$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rolinson, G. N.</creatorcontrib><title>Bacterial Resistance to Penicillins and Cephalosporins</title><title>Proceedings of the Royal Society of London. Series B, Biological sciences</title><addtitle>Proc. R. Soc. Lond. B</addtitle><addtitle>Proc R Soc Lond B Biol Sci</addtitle><description>The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtieth anniversary of the introduction of penicillin into medicine it seemed to me that it would be appropriate to consider primarily the changes which have taken place over this period in the incidence of resistance and the knowledge which has been gained concerning the nature of resistance to this family of antibiotics. Before we look at what the changes in resistance have been, however, it may be useful to consider what one means by the word resistant, and in fact one uses the word in two rather different ways. Used in one sense the term applies to those species of bacteria which are characteristically insensitive to penicillin, for example one may say that Pseudomonas aeruginosa is resistant to benzylpenicillin, because this is a characteristic of the species. On the other hand, the term resistant is also applied to particular strains of species of bacteria which are typically penicillin sensitive, or at least were typically sensitive at the time penicillin was first introduced into medicine, for example penicillin-resistant strains of staphylococci and penicillinresistant gonococci. As a result of these two uses of the word resistant some anomalies appear to arise. For example, strains of Escherichia coli inhibited by ampicillin at a concentration of 2 μg/ml would certainly be considered sensitive, whereas strains of gonococci inhibited by one-tenth of this concentration would be regarded as resistant and this is because typical sensitive strains are inhibited by even lower levels. Again, strains of Ps. aeruginosa requiring for inhibition a concentration of gentamicin of 10 μg/ml would be said to be resistant, but strains inhibited by carbenicillin at a level as high as 50 μg/ml are considered sensitive. Here the reason is toxicity: a level of 10 μg/ml of gentamicin could not safely be maintained in the body, whereas a level of 50 μg/ml carbenicillin can. Clearly there are two criteria for judging organisms to be resistant, one is that the concentration of drug required to inhibit growth is a level which cannot readily be achieved at the site of infection and the other is simply that the minimum inhibitory concentration is significantly higher than that of the majority of strains of that particular species. Resistance to penicillins and cephalosporins, as with other antibiotics, may arise in bacteria in one of two ways. Resistance may occur as a result of chromosomal mutation or it may arise as a result of the transfer of genetic information from a resistant bacterial cell to a sensitive cell and this transfer may take place by transformation or by conjugation or by the phage mediated process of transduction. Resistant strains, once they arise, may be at a selectional advantage when the drug is used and as a result they may become more prevalent. The frequency at which antibiotic resistant strains arise, and the rate at which they subsequently increase in numbers, varies greatly with different antibiotics and different pathogens and some of the changes in bacterial resistance to penicillins which have occurred over the past 30 years are shown in diagrammatic form in figure 1.</description><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Cephalosporins</subject><subject>Cephalosporins - pharmacology</subject><subject>Enterobacteriaceae - drug effects</subject><subject>Enterobacteriaceae - enzymology</subject><subject>Enterococcus faecalis - drug effects</subject><subject>Escherichia coli - drug effects</subject><subject>Haemophilus influenzae - drug effects</subject><subject>Infections</subject><subject>Klebsiella</subject><subject>Klebsiella - drug effects</subject><subject>Mutation</subject><subject>Neisseria gonorrhoeae</subject><subject>Neisseria gonorrhoeae - drug effects</subject><subject>Pathogens</subject><subject>Penicillin</subject><subject>Penicillin Resistance</subject><subject>Penicillinase - metabolism</subject><subject>Penicillins - pharmacology</subject><subject>Proteus mirabilis - drug effects</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Staphylococcus</subject><subject>Staphylococcus - drug effects</subject><subject>Streptococcus pyogenes - drug effects</subject><subject>Structure-Activity Relationship</subject><subject>Transformation, Genetic</subject><issn>0080-4649</issn><issn>0950-1193</issn><issn>2053-9193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1971</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1r3DAQxUVpSbdJrz0UCj715s3oy5aOzdIvCCSk6Vlo5RHV4rVcyQ5s__rK2SVQSnsSo_nNm3mPkDcU1hS0ukx53K6pbukaKMhnZMVA8lpTzZ-TFYCCWjRCvySvct4BiEZrfkbOhAAqqFqR5sq6CVOwfXWHOeTJDg6rKVa3OAQX-j4MubJDV21w_GH7mMeYytcFeeFtn_H16T0n3z99vN98qa9vPn_dfLiuHdd8qr2gVkq0QumOecrQqdZ3IISjkjkUtjjQgjHPvZe-a6TGrReWMRCoLG75OXl_1B1T_Dljnsw-ZId9bweMczaK8mKbQwHXR9ClmHNCb8YU9jYdDAWzBGWWoMwSlFmCKgPvTsrzdo_dE35KpvTzsZ_ioTiMLuB0MLs4p6GU5u7b7RXVUj_QVoei1xpQnEIDlDXmVxgf1y2AKYAJOc9oHrE_z_j7Kv6_rf_08vY4tctTTE9WWqkV8N9q-qMo</recordid><startdate>19711231</startdate><enddate>19711231</enddate><creator>Rolinson, G. N.</creator><general>The Royal Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19711231</creationdate><title>Bacterial Resistance to Penicillins and Cephalosporins</title><author>Rolinson, G. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-f41a55ea489d2f12ec87fd044c152ce4a0989422f3ff5fd659ebf4a2204e8aeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1971</creationdate><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Cephalosporins</topic><topic>Cephalosporins - pharmacology</topic><topic>Enterobacteriaceae - drug effects</topic><topic>Enterobacteriaceae - enzymology</topic><topic>Enterococcus faecalis - drug effects</topic><topic>Escherichia coli - drug effects</topic><topic>Haemophilus influenzae - drug effects</topic><topic>Infections</topic><topic>Klebsiella</topic><topic>Klebsiella - drug effects</topic><topic>Mutation</topic><topic>Neisseria gonorrhoeae</topic><topic>Neisseria gonorrhoeae - drug effects</topic><topic>Pathogens</topic><topic>Penicillin</topic><topic>Penicillin Resistance</topic><topic>Penicillinase - metabolism</topic><topic>Penicillins - pharmacology</topic><topic>Proteus mirabilis - drug effects</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Staphylococcus</topic><topic>Staphylococcus - drug effects</topic><topic>Streptococcus pyogenes - drug effects</topic><topic>Structure-Activity Relationship</topic><topic>Transformation, Genetic</topic><toplevel>online_resources</toplevel><creatorcontrib>Rolinson, G. N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Proceedings of the Royal Society of London. Series B, Biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rolinson, G. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacterial Resistance to Penicillins and Cephalosporins</atitle><jtitle>Proceedings of the Royal Society of London. Series B, Biological sciences</jtitle><stitle>Proc. R. Soc. Lond. B</stitle><addtitle>Proc R Soc Lond B Biol Sci</addtitle><date>1971-12-31</date><risdate>1971</risdate><volume>179</volume><issue>1057</issue><spage>403</spage><epage>410</epage><pages>403-410</pages><issn>0080-4649</issn><issn>0950-1193</issn><eissn>2053-9193</eissn><abstract>The subject of bacterial resistance to penicillins and cephalosporins could be discussed from a number of points of view and clearly it is not possible in the time available to review adequately every aspect. Some selection is necessary and bearing in mind that the Symposium commemorates the thirtieth anniversary of the introduction of penicillin into medicine it seemed to me that it would be appropriate to consider primarily the changes which have taken place over this period in the incidence of resistance and the knowledge which has been gained concerning the nature of resistance to this family of antibiotics. Before we look at what the changes in resistance have been, however, it may be useful to consider what one means by the word resistant, and in fact one uses the word in two rather different ways. Used in one sense the term applies to those species of bacteria which are characteristically insensitive to penicillin, for example one may say that Pseudomonas aeruginosa is resistant to benzylpenicillin, because this is a characteristic of the species. On the other hand, the term resistant is also applied to particular strains of species of bacteria which are typically penicillin sensitive, or at least were typically sensitive at the time penicillin was first introduced into medicine, for example penicillin-resistant strains of staphylococci and penicillinresistant gonococci. As a result of these two uses of the word resistant some anomalies appear to arise. For example, strains of Escherichia coli inhibited by ampicillin at a concentration of 2 μg/ml would certainly be considered sensitive, whereas strains of gonococci inhibited by one-tenth of this concentration would be regarded as resistant and this is because typical sensitive strains are inhibited by even lower levels. Again, strains of Ps. aeruginosa requiring for inhibition a concentration of gentamicin of 10 μg/ml would be said to be resistant, but strains inhibited by carbenicillin at a level as high as 50 μg/ml are considered sensitive. Here the reason is toxicity: a level of 10 μg/ml of gentamicin could not safely be maintained in the body, whereas a level of 50 μg/ml carbenicillin can. Clearly there are two criteria for judging organisms to be resistant, one is that the concentration of drug required to inhibit growth is a level which cannot readily be achieved at the site of infection and the other is simply that the minimum inhibitory concentration is significantly higher than that of the majority of strains of that particular species. Resistance to penicillins and cephalosporins, as with other antibiotics, may arise in bacteria in one of two ways. Resistance may occur as a result of chromosomal mutation or it may arise as a result of the transfer of genetic information from a resistant bacterial cell to a sensitive cell and this transfer may take place by transformation or by conjugation or by the phage mediated process of transduction. Resistant strains, once they arise, may be at a selectional advantage when the drug is used and as a result they may become more prevalent. The frequency at which antibiotic resistant strains arise, and the rate at which they subsequently increase in numbers, varies greatly with different antibiotics and different pathogens and some of the changes in bacterial resistance to penicillins which have occurred over the past 30 years are shown in diagrammatic form in figure 1.</abstract><cop>London</cop><pub>The Royal Society</pub><pmid>4401418</pmid><doi>10.1098/rspb.1971.0105</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0080-4649
ispartof Proceedings of the Royal Society of London. Series B, Biological sciences, 1971-12, Vol.179 (1057), p.403-410
issn 0080-4649
0950-1193
2053-9193
language eng
recordid cdi_jstor_primary_75980
source Jstor Complete Legacy; MEDLINE
subjects Antibiotics
Bacteria
Cephalosporins
Cephalosporins - pharmacology
Enterobacteriaceae - drug effects
Enterobacteriaceae - enzymology
Enterococcus faecalis - drug effects
Escherichia coli - drug effects
Haemophilus influenzae - drug effects
Infections
Klebsiella
Klebsiella - drug effects
Mutation
Neisseria gonorrhoeae
Neisseria gonorrhoeae - drug effects
Pathogens
Penicillin
Penicillin Resistance
Penicillinase - metabolism
Penicillins - pharmacology
Proteus mirabilis - drug effects
Pseudomonas aeruginosa - drug effects
Staphylococcus
Staphylococcus - drug effects
Streptococcus pyogenes - drug effects
Structure-Activity Relationship
Transformation, Genetic
title Bacterial Resistance to Penicillins and Cephalosporins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A46%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacterial%20Resistance%20to%20Penicillins%20and%20Cephalosporins&rft.jtitle=Proceedings%20of%20the%20Royal%20Society%20of%20London.%20Series%20B,%20Biological%20sciences&rft.au=Rolinson,%20G.%20N.&rft.date=1971-12-31&rft.volume=179&rft.issue=1057&rft.spage=403&rft.epage=410&rft.pages=403-410&rft.issn=0080-4649&rft.eissn=2053-9193&rft_id=info:doi/10.1098/rspb.1971.0105&rft_dat=%3Cjstor_proqu%3E75980%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81301030&rft_id=info:pmid/4401418&rft_jstor_id=75980&rfr_iscdi=true